Ziyad M. Hijazi, MD, MPH

Transcatheter Closure of Congenital and Acquired Muscular Ventricular Septal Defects Using the Amplatzer¬Æ Device

08/01/2008

Surgical closure of congenital or acquired [post-myocardial infarction (MI)] muscular ventricular septal defects (MVSD) is still associated with significant mortality and long-term morbidity.1,2 Different surgical approaches have been...

Surgical closure of congenital...

08/01/2008

Journal of Invasive Cardiology

Review

Transcatheter Closure of Secundum Atrial Septal Defect in the Elderly

02/11/2009

Ahmad Al-Hindi , MD;

Qi-Ling Cao , MD;

Ziyad M. Hijazi , MD, MPH;

From the Rush Center For Congenital & Structural Heart Disease, Rush University Medical Center, Chicago, Illinois. Disclosure: Dr. Hijazi is a non-paid consultant to Occlutech, a German device company. Manuscript submitted November 10, 2008...

From the Rush Center For...

02/11/2009

Journal of Invasive Cardiology

Percutaneous Closure of a Post-traumatic Muscular Ventricular Septal Defect Using the Amplatzer Duct Occluder

08/01/2008

Ziyad M. Hijazi , MD, MPH;

Roberto M. Lang , MD;

Stephanie Schwalm , MD;

Post-traumatic ventricular septal defect (VSD) after penetrating cardiac trauma is infrequent, with an estimated incidence of 1–4.5% of cases.1,3 The decision to close a traumatic VSD is similar to that of a non-traumatic VSD and is based on...

Post-traumatic ventricular...

08/01/2008

Journal of Invasive Cardiology

Review

Transcatheter Closure of Secundum Atrial Septal Defects

04/25/2013

Clifford J. Kavinsky , MD, PhD;

Damien P. Kenny , MB, MD, MRCPCh;

Suhaib Kazmouz , MD;

Qi-Ling Cao , MD;

Ziyad M. Hijazi , MD, MPH;

Atrial septal defect (ASD) is one of the most common congenital heart defects accounting for 7%-10% of all congenital heart disease in children and 30%-33% of defects diagnosed in adults with congenital heart disease. This review highlights...

Atrial septal defect (ASD) is...

04/25/2013

Journal of Invasive Cardiology

Use of Endovascular Stents for the Treatment of Coarctation of the Aorta in Children and Adults: Immediate and Midterm Results

08/01/2008

Qi-Ling Cao , MD;

Lisa Shah , MD;

Ziyad M. Hijazi , MD, MPH;

Satindir K. Sandhu , MD;

Annette Joseph , RN;

Coarctation of the aorta (CoA) accounts for 6–8% of all forms of congenital heart defects. In children and adults, balloon angioplasty has become the preferred treatment for patients with recurrent CoA.1–5,6–18 The application of this...

Coarctation of the aorta (CoA)...

08/01/2008

Journal of Invasive Cardiology

Invasive Thoughts

The RESPECT Trial: What Will the FDA Do?

11/29/2012

Ziyad M. Hijazi , MD, MPH;

One of the many shortcomings of comparative observational studies examining patent foramen ovale (PFO) closure versus medical management included in meta-analysis is failure to adjust for potential confounders; therefore, the need for...

One of the many shortcomings of...

11/29/2012

Journal of Invasive Cardiology